Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study (BMC Pulmonary Medicine, (2021), 21, 1, (165), 10.1186/s12890-021-01530-6)
Tang Hsiu Huang, Chin Wei Kuo, Chian Wei Chen, Yau Lin Tseng, Chao Liang Wu, Sheng Hsiang Lin
研究成果: Comment/debate › 同行評審